| Product dosage: 15mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.95 | $57.06 (0%) | 🛒 Add to cart |
| 90 | $0.83 | $85.60 $75.08 (12%) | 🛒 Add to cart |
| 120 | $0.78 | $114.13 $93.10 (18%) | 🛒 Add to cart |
| 180 | $0.72 | $171.19 $129.14 (25%) | 🛒 Add to cart |
| 240 | $0.69 | $228.26 $166.19 (27%) | 🛒 Add to cart |
| 360 | $0.66
Best per pill | $342.38 $239.27 (30%) | 🛒 Add to cart |
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.87 | $52.06 (0%) | 🛒 Add to cart |
| 90 | $0.77 | $78.09 $69.08 (12%) | 🛒 Add to cart |
| 120 | $0.72 | $104.12 $86.10 (17%) | 🛒 Add to cart |
| 180 | $0.66 | $156.17 $118.13 (24%) | 🛒 Add to cart |
| 270 | $0.63 | $234.26 $169.19 (28%) | 🛒 Add to cart |
| 360 | $0.60
Best per pill | $312.35 $217.24 (30%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Actos: Significant Glycemic Control for Type 2 Diabetes - Evidence-Based Review
Actos (pioglitazone hydrochloride) represents one of the more controversial yet clinically valuable oral antidiabetic agents in the thiazolidinedione class. Initially approved by the FDA in 1999, this medication has demonstrated significant efficacy in improving glycemic control through its unique mechanism of insulin sensitization, though its journey has been marked by both therapeutic triumphs and serious safety debates that every prescribing clinician should understand thoroughly. 1. Introduction: What is Actos? Its Role in Modern Medicine What is Actos exactly?
accupril
Accupril is a well-established angiotensin-converting enzyme (ACE) inhibitor, specifically quinapril hydrochloride, used primarily in the management of hypertension and as adjunctive therapy in heart failure. It works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, thereby promoting vasodilation and reducing aldosterone secretion, which decreases sodium and water retention. This monograph provides a comprehensive, evidence-based review of Accupril, detailing its clinical applications, pharmacokinetics, safety profile, and practical considerations for use, aimed at healthcare professionals and informed patients seeking in-depth understanding.
Anafranil: Effective Symptom Control for Obsessive-Compulsive Disorder - Evidence-Based Review
Anafranil, known generically as clomipramine hydrochloride, is a tricyclic antidepressant (TCA) belonging to the dibenzazepine class. It functions primarily as a potent serotonin reuptake inhibitor, though it also affects norepinephrine reuptake to a lesser extent. Marketed extensively for the treatment of obsessive-compulsive disorder (OCD), its application extends to major depressive disorder, panic disorder, and certain chronic pain conditions. The drug is available in oral formulations, typically as 10 mg, 25 mg, and 50 mg capsules or tablets, designed for systemic absorption and central nervous system activity.
Arimidex: Potent Estrogen Suppression for Breast Cancer Treatment - Evidence-Based Review
Anastrozole, marketed under the brand name Arimidex, represents a significant advancement in endocrine therapy for hormone receptor-positive breast cancer. As a non-steroidal aromatase inhibitor, it works by selectively blocking the aromatase enzyme, which is responsible for converting androgens into estrogens in peripheral tissues. This mechanism is particularly crucial in postmenopausal women, where ovarian estrogen production has ceased, and peripheral aromatization becomes the primary source of circulating estrogens. The clinical implications of this targeted approach have fundamentally changed how we manage hormone-sensitive breast malignancies in postmenopausal populations.
Atorlip 10: Effective Cholesterol Management for Cardiovascular Health - Evidence-Based Review
Before we get to the formal monograph, let me give you the real story on Atorlip 10. When our team first started working on this generic atorvastatin formulation back in 2018, we had three pharmacists and two physicians arguing constantly about the excipient matrix. Dr. Chen kept insisting we needed the full patented crystalline form, while our lead formulator Maria argued that the amorphous dispersion technology would give us comparable bioavailability at half the production cost.
Atorlip 20: Effective Cholesterol Management for Cardiovascular Risk Reduction - Evidence-Based Review
Atorlip 20 represents a significant advancement in lipid management therapy, specifically formulated as a 20mg atorvastatin tablet for patients requiring moderate-intensity statin treatment. Having prescribed various statins over fifteen years of cardiology practice, I’ve observed how this particular dosage often becomes the therapeutic sweet spot for many patients - effective enough to achieve LDL-C targets without pushing into the high-intensity range where side effects become more problematic. The development team actually debated extensively about whether to launch with 10mg or 20mg as the entry formulation, with the clinical research division arguing that starting at 20mg would help more patients reach guideline-directed goals faster.
Atorlip 5: Targeted Cholesterol Management for Borderline Hyperlipidemia - Evidence-Based Review
Atorlip 5 represents one of those interesting cases where pharmaceutical-grade thinking meets dietary supplement formulation. We’re looking at a 5mg atorvastatin supplement positioned for cholesterol management in the borderline-high range - that 200-239 mg/dL LDL sweet spot where many clinicians debate intervention strategies. What fascinates me about this product isn’t just the active ingredient, but the delivery system they’ve developed, which I’ll get into shortly. The formulation includes a proprietary absorption enhancement technology that apparently increases bioavailability compared to standard atorvastatin, though the clinical significance of this remains debated within our cardiology department.
Avapro: Effective Blood Pressure Control and Renal Protection in Hypertension and Diabetes - Evidence-Based Review
Irbesartan, marketed under the brand name Avapro, is an angiotensin II receptor blocker (ARB) prescribed primarily for managing hypertension and providing nephroprotection in patients with type 2 diabetes and hypertension. It selectively blocks the binding of angiotensin II to the AT1 receptor, which is found in many tissues, leading to vasodilation, reduced aldosterone secretion, and decreased blood pressure. Unlike ACE inhibitors, irbesartan does not affect bradykinin metabolism, which may reduce the incidence of cough as a side effect.
cabgolin
Cabgolin is a pharmaceutical preparation containing the active substance cabergoline, a potent dopamine receptor agonist. It’s primarily indicated for the treatment of hyperprolactinemic disorders, Parkinson’s disease, and off-label uses in endocrine conditions. The product typically comes in 0.5 mg tablet form with distinctive scoring for precise dose titration. What’s interesting about cabergoline compared to older ergot derivatives is its exceptionally long half-life - we’re talking 63-69 hours in healthy volunteers - which allows for convenient once or twice weekly dosing in most protocols.